AMIR
AI-Powered Pharmaceutical Research — from hypothesis to development dossier.
About AMIR
AMIR (Artificial Medical Intelligence Researcher) transforms weeks of pharmaceutical research into hours. Generate comprehensive 200+ page development dossiers including literature synthesis, therapeutic hypotheses, regulatory strategy across FDA/EMA/PMDA/NMPA, clinical trial designs, and investor materials — all from a single condition input.
Features
80+ stage AI pipeline for comprehensive analysis
Literature synthesis across 8 research domains
10 ranked therapeutic hypotheses with deep-dives
Global regulatory strategy: FDA, EMA, PMDA, NMPA
Clinical trial concepts with protocol synopses
Prior art analysis and IP strategy
Budget projections and investor materials
Export: 200+ page PDF with clickable TOC
Pharma R&D Biotech Regulatory Clinical Trials AI Research
Plans & Pricing — AMIR Research Reports
| Report Tier | Research Domains | Hypotheses | Regulatory Regions |
|---|---|---|---|
| Quick | 4 | 5 (3 detailed) | 2 |
| Detailed | 6 | 8 (5 detailed) | 3 |
| Comprehensive | 8 | 10 (all detailed) | 4 |
Contact us for pricing. Special pricing available for academic researchers. Reports generated in 2-4 hours.
Media
Click any thumbnail to view in a lightbox.
Ready to get started?
Tell us about your use case and we will show you how AMIR can work for your business.